UKALL14 sub study
Acute lymphoblastic leukaemia (ALL) / Posted 1 year ago
The UKALL14 trial is looking at different treatments for ALL.
The team would now like to do a sub study to find out more about the genes of the leukaemic cells. They also want to find out more about whether they can predict how well treatment will work based on these changes.
In this study you have the standard chemotherapy treatment for ALL at your hospital. The study team will ask for small amount of your bone marrow sample that is taken before starting your treatment.
They are looking for a substance (biomarker ) in the sample they can use to follow how well your leukaemia responds to treatment. They are also looking for any gene changes in the cells of your leukaemia.